Results 31 to 40 of about 578,524 (300)

Analysis of cause-specific atherothrombotic cardiovascular disease mortality in Mexico: 2011–2015

open access: yesArchives of Medical Science, 2022
Introduction In Mexico, cardiovascular diseases (CVD) represent the most important cause of mortality, disability, and premature death. We aimed to analyze the mortality rate due to specific causes of atherothrombotic CVD, from 2011 to 2015.
Erwin Chiquete   +8 more
doaj   +1 more source

Sudden cardiac death in patients with ischemic heart failure undergoing coronary artery bypass grafting results from the STICH randomized clinical trial (Surgical Treatment for Ischemic Heart Failure) [PDF]

open access: yes, 2017
Background—The risk of sudden cardiac death (SCD) in patients with heart failure following CABG has not been examined in a contemporary clinical trial of surgical revascularization. This analysis describes the incidence, timing and clinical predictors of
Al-Khatib, Sana M.   +19 more
core   +2 more sources

Research on heart failure in Colombia, time to take a step forward

open access: yesRevista de la Facultad de Medicina, 2018
Cardiovascular diseases are the leading cause of death worldwide. According to the Ministry of Health, in Colombia, cardiac ischemic disease ranks first, followed by stroke, diabetes and hypertensive heart disease, which are in the top ten sources of ...
Guillermo Mora Pabón
doaj   +1 more source

The Arachidonate 15-Lipoxygenase Enzyme Product 15-HETE Is Present in Heart Tissue from Patients with Ischemic Heart Disease and Enhances Clot Formation. [PDF]

open access: yesPLoS ONE, 2016
Ischemic heart disease is a major cause of death and morbidity and the search for novel therapeutic targets is still required. We have previously shown that the enzyme arachidonate 15 lipoxygenase (ALOX15), which catalyzes the conversion of arachidonic ...
Annika Lundqvist   +6 more
doaj   +1 more source

Stroke following percutaneous coronary intervention : type-specific incidence, outcomes and determinants seen by the British Cardiovascular Intervention Society 2007-12 [PDF]

open access: yes, 2016
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2015.
Berry, Colin   +11 more
core   +1 more source

Small Vessel Disease in the Heart and Brain: Current Knowledge, Unmet Therapeutic Need and Future Directions [PDF]

open access: yes, 2019
No abstract ...
Berry, C   +6 more
core   +2 more sources

Dynamics of parameters of oxidative stress in blood of ischemic heart disease patients before and after coronary bypass surgery

open access: yesБюллетень сибирской медицины, 2012
Study the dynamics of oxidative stress in the blood of patients with ischemic heart disease before and after on-pump coronary bypass surgery. 27 ischemic heart disease patients were examined.
N. L. Vorontsova   +7 more
doaj   +1 more source

Ischemic Heart Disease

open access: yes, 2021
All over the world ischemic heart disease remains as the leading cause of death, followed by stroke. Ischemic heart disease, also called coronary artery disease has a broad spectrum of clinical manifestations from the acute coronary syndromes which include, unstable angina pectoris and acute myocardial infarction with and without elevation of the ST ...
López, De Lucio, Saraí   +1 more
openaire   +3 more sources

The Aging Blood: Cellular Origins, Circulating Drivers, and Therapeutic Potential

open access: yesAging and Cancer, EarlyView.
As a conduit linking all organs, the blood system both reflects and actively drives systemic aging. This review highlights how circulating pro‐aging and antiaging factors and age‐associated hematopoietic stem cell dysfunction contribute to immunosenescence and multi‐organ decline, positioning the hematopoietic system as a target for aging intervention.
Hanqing He, Jianwei Wang
wiley   +1 more source

Familial Aggregation for Ischemic Heart Disease

open access: yesRevista Finlay, 2022
Background: ischemic heart disease is a nosological entity of multifactorial origin with genetic predisposition and susceptible to environmental changes. Objective: to determine the existence of familial aggregation for ischemic heart disease in patients
José Leandro Pérez Guerrero   +1 more
doaj  

Home - About - Disclaimer - Privacy